Galenica Ltd. AGM Approves Dividend Increase and Capital Flexibility

The Annual General Meeting of Galenica Ltd. supported all motions from the Board of Directors. Shareholders re-elected all board members and approved a dividend increase of 8.7% to CHF 2.50 per share, resulting in a CHF 125.0 million payout. This decision aligns with Galenica's sustainable dividend strategy aimed at maintaining the dividend level for the next financial year.

Additionally, the introduction of a capital range was approved, providing strategic flexibility for future financial adjustments. Dr. Markus R. Neuhaus was re-elected as Chairman with strong support.

The meeting had significant participation, with 496 shareholders representing 75.2% of registered voting shares. These developments reflect shareholder confidence in Galenica's strategic direction and long-term healthcare system contributions in Switzerland.